Sustained SN38 release from EZN-2208 in the tumor stroma may counteract cellular ABCG2-mediated efflux and maintain a steep diffusion gradient towards the topoisomerase I target within the tumor cell nuclei. Here, ABCG2 is linked to neoplasm.